NCT00792272

Brief Summary

Dialysis patient could be more aspirin resistant than the general population based on data from chronic kidney disease patients

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2008

Shorter than P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2008

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2008

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

November 14, 2008

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 17, 2008

Completed
Last Updated

July 22, 2013

Status Verified

July 1, 2013

Enrollment Period

5 months

First QC Date

November 14, 2008

Last Update Submit

July 19, 2013

Conditions

Keywords

aspirin resistanceaspirin resistance in hemodialysis patients

Outcome Measures

Primary Outcomes (1)

  • Aspirin Resistance in Hemodialysis patients

    2 months

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

all hemodialysis patients on aspirin

You may qualify if:

  • all hemodialysis patients on aspirin

You may not qualify if:

  • low platelets \<100.000
  • coagulopathy, bleeding disorders
  • patient on plavix

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Suzanne El-Sayegh, MD

    SIUH

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Chair of Medicine

Study Record Dates

First Submitted

November 14, 2008

First Posted

November 17, 2008

Study Start

June 1, 2008

Primary Completion

November 1, 2008

Study Completion

November 1, 2008

Last Updated

July 22, 2013

Record last verified: 2013-07